Image

Performance of CO2-derived Parameters in Predicting Low Cardiac Output Syndrome

Performance of CO2-derived Parameters in Predicting Low Cardiac Output Syndrome

Recruiting
17 years and younger
All
Phase N/A

Powered by AI

Overview

In congenital cardiac intensive care, low cardiac output syndrome (LCOS) after surgery is defined by a decrease in cardiac output due to cardiac dysfunction. This syndrome is responsible for postoperative mortality and morbidity, as well as prolonged hospitalization.

CO2-derived parameters are increasingly used to identify low cardiac output status by the PCO2 gap, or anaerobic metabolism by the Pv-aCO2/Ca-vO2 ratio, particularly in septic shock in adults, with or without hypoxemia. The thresholds proposed as pathological values were a PCO2 gap ≥ 6 mmHg and a Pv-aCO2/Ca-vO2 ratio ≥ 1.4 mmHg/ml. However, these markers have not been studied in depth in patients who have undergone cardiac surgery. In adults, studies have focused on the predictive value of the PCO2 gap and Pv-aCO2/Ca-vO2 on postoperative complications. In the pediatric population following cardiac surgery, only retrospective studies exist, with conflicting results on the correlation between the PCO2 gap and cardiac output, and the PCO2 gap and duration of mechanical ventilation.

This study aims to compare the performance of CO2-derived parameters in predicting LCOS and anaerobic metabolism in children after cardiac surgery with cardiopulmonary bypass.

Eligibility

Inclusion Criteria:

  • Children under the age of 18
  • Post-operative cardiac surgery
  • Surgery with extracorporeal circulation
  • With a central venous catheter and an arterial catheter
  • Admitted to the pediatric intensive care unit at Lille University Hospital
  • Patient covered by the social security system (or equivalent)

Exclusion Criteria:

  • Pre-existing renal insufficiency prior to cardiac surgery
  • Opposition from the holder of parental authority
  • Difficulty understanding or communicating, making it impossible to inform the holder of parental authority
  • Patient under legal protection (guardianship, curatorship, legal safeguard)
  • Malposition of the central venous catheter
  • Malposition of the arterial catheter
  • Biological samples that cannot be interpreted

Study details
    Low Cardiac Output Syndrome Bypass Children

NCT07770386

University Hospital, Lille

22 August 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.